Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06151821
Status:
COMPLETED
Last Update Posted:
2023-11-30
First Post:
2023-08-02
Brief Title:
Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control
Sponsor:
Shifa International Hospital
Organization:
Shifa International Hospital
Study Overview
Official Title:
Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control A Randomized Controlled Trial Among Hospitalized Type 1 Adolescent Diabetic Patients
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study aims to investigate the effects of Guided Meditation on diabetes-related distress and glycemic control in hospitalized Type 1 adolescent diabetic patients The study will employ a randomized controlled trial design with participants randomly assigned to either the intervention group receiving Guided Meditation sessions or the control group receiving standard care The primary outcomes measured will be diabetes-related distress levels and glycemic control HbA1c levels
Detailed Description:
The researchers hypothesize that the intervention group will experience a reduction in diabetes-related distress and an improvement in glycemic control compared to the control group The studys findings could suggest how guided meditation could help manage the emotional distress and enhance diabetes management in hospitalized Type 1 adolescent diabetic patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None